HuGE Literature Finder
Records 1-14
|
Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients.
International journal of clinical oncology 2021 Jan . Feng Feiling, Wu Xiaobing, Shi Xiaoliang, Gao Qingxiang, Wu Yue, Yu Yong, Cheng Qingbao, Li Bin, Yi Bin, Liu Chen, Hao Qing, Zhang Lin, Gao Chunfang, Jiang Xiaoqi |
|
Characteristics of genomic alterations in Chinese cholangiocarcinoma patients.
Japanese journal of clinical oncology 2020 Jun . Jiang Guoping, Zhang Wu, Wang Ting, Ding Songming, Shi Xiaoliang, Zhang Shuirong, Shi Weiwei, Liu Angen, Zheng Shus |
|
Genomic characterization of cholangiocarcinoma in primary sclerosing cholangitis reveals novel therapeutic opportunities.
Hepatology (Baltimore, Md.) 2020 Jan . Goeppert Benjamin, Folseraas Trine, Roessler Stephanie, Kloor Matthias, Volckmar Anna-Lena, Endris Volker, Buchhalter Ivo, Stenzinger Albrecht, Grzyb Krzysztof, Grimsrud Marit M, Gornicka Barbara, von Seth Erik, Reynolds Gary M, Franke Andre, Gotthardt Daniel N, Mehrabi Arianeb, Cheung Angela, Verheij Joanne, Arola Johanna, Mäkisalo Heikki, Eide Tor J, Weidemann Sören, Cheville John C, Mazza Giuseppe, Hirschfield Gideon M, Ponsioen Cyriel Y, Bergquist Annika, Milkiewicz Piotr, Lazaridis Konstantinos N, Schramm Christoph, Manns Michael P, Färkkilä Martti, Vogel Arndt, , Boberg Kirsten M, Schirmacher Peter, Karlsen Tom |
|
Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker.
European journal of cancer (Oxford, England : 1990) 2019 Aug 120 31-39. Chae Heejung, Kim Deokhoon, Yoo Changhoon, Kim Kyu-Pyo, Jeong Jae Ho, Chang Heung-Moon, Lee Sang Soo, Park Do Hyun, Song Tae Jun, Hwang Shin, Kim Ki-Hun, Song Gi-Won, Ahn Chul Soo, Lee Jae Hoon, Hwang Dae Wook, Kim Song Cheol, Jang Se Jin, Hong Seung-Mo, Kim Tae Won, Ryoo Baek-Ye |
|
Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification?
HPB : the official journal of the International Hepato Pancreato Biliary Association 2019 May . Bagante Fabio, Ruzzenente Andrea, Conci Simone, Rusev Borislav C, Simbolo Michele, Campagnaro Tommaso, Pawlik Timothy M, Luchini Claudio, Iacono Calogero, Scarpa Aldo, Guglielmi Alfre |
|
Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection.
Journal of surgical oncology 2019 Jan 119 (1): 40-46. Huang Jianbo, Wang Xiangyu, Zhu Ying, Wang Zheng, Li Jianhua, Xu Da, Wang Shenghao, Li Tian-En, Lu |
|
ACGH detects distinct genomic alterations of primary intrahepatic cholangiocarcinomas and matched lymph node metastases and identifies a poor prognosis subclass.
Scientific reports 2018 Jul 8 (1): 10637. Jansen Ruben, Moehlendick Birte, Bartenhagen Christoph, Tóth Csaba, Lehwald Nadja, Stoecklein Nikolas H, Knoefel Wolfram T, Lachenmayer An |
|
Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations.
Oncotarget 2016 Mar . Kim Young-Ho, Hong Eun-Kyung, Kong Sun-Young, Han Sung-Sik, Kim Seoung-Hoon, Rhee Je-Keun, Hwang Soo-Kyung, Park Sang-Jae, Kim Tae-M |
|
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
Annals of surgical oncology 2015 Dec . Ruzzenente Andrea, Fassan Matteo, Conci Simone, Simbolo Michele, Lawlor Rita T, Pedrazzani Corrado, Capelli Paola, D'Onofrio Mirko, Iacono Calogero, Scarpa Aldo, Guglielmi Alfre |
|
Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets.
Annals of surgical oncology 2014 Nov 21 (12): 3827-34. Zhu Andrew X, Borger Darrell R, Kim Yuhree, Cosgrove David, Ejaz Aslam, Alexandrescu Sorin, Groeschl Ryan Thomas, Deshpande Vikram, Lindberg James M, Ferrone Cristina, Sempoux Christine, Yau Thomas, Poon Ronnie, Popescu Irinel, Bauer Todd W, Gamblin T Clark, Gigot Jean Francois, Anders Robert A, Pawlik Timothy |
|
Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2014 Jan 27 (1): 73-86. Schlitter Anna Melissa, Born Diana, Bettstetter Marcus, Specht Katja, Kim-Fuchs Corina, Riener Marc-Oliver, Jeliazkova Petia, Sipos Bence, Siveke Jens T, Terris Benoit, Zen Yoh, Schuster Tibor, Höfler Heinz, Perren Aurel, Klöppel Günter, Esposito Ire |
|
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
PloS one 2014 9 (12): e115383. Churi Chaitanya R, Shroff Rachna, Wang Ying, Rashid Asif, Kang HyunSeon C, Weatherly Jacqueline, Zuo Mingxin, Zinner Ralph, Hong David, Meric-Bernstam Funda, Janku Filip, Crane Christopher H, Mishra Lopa, Vauthey Jean-Nicholas, Wolff Robert A, Mills Gordon, Javle Mili |
|
Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis.
PloS one 2012 7 (6): e37707. Villar Stephanie, Ortiz-Cuaran Sandra, Abedi-Ardekani Behnoush, Gouas Doriane, Nogueira da Costa Andre, Plymoth Amelie, Khuhaprema Thiravud, Kalalak Anant, Sangrajrang Suleeporn, Friesen Marlin D, Groopman John D, Hainaut Pier |
|
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping.
The oncologist 2012 17 (1): 72-9. Borger Darrell R, Tanabe Kenneth K, Fan Kenneth C, Lopez Hector U, Fantin Valeria R, Straley Kimberly S, Schenkein David P, Hezel Aram F, Ancukiewicz Marek, Liebman Hannah M, Kwak Eunice L, Clark Jeffrey W, Ryan David P, Deshpande Vikram, Dias-Santagata Dora, Ellisen Leif W, Zhu Andrew X, Iafrate A Jo |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: